Trials / Recruiting
RecruitingNCT02686125
Vercise™ DBS Dystonia Prospective Study
Prospective Study of Deep Brain Stimulation With the VERCISE™ System for Treatment of Dystonia
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 7 Years
- Healthy volunteers
- Not accepted
Summary
To compile characteristics of real-world outcomes of Boston Scientific Corporation's commercially approved VerciseTM Deep Brain Stimulation (DBS) Systems for the treatment of dystonia.
Detailed description
To compile characteristics of real-world outcomes of Boston Scientific Corporation's commercially approved VerciseTM Deep Brain Stimulation (DBS) Systems for the treatment of dystonia. Subjects' improvement in disease symptoms and overall Quality of life will be assessed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Deep Brain Stimulation (DBS) | Subjects receiving Deep Brain Stimulation (DBS) for the treatment of their dystonia symptoms will be offered participation in this registry. |
Timeline
- Start date
- 2016-03-07
- Primary completion
- 2030-12-01
- Completion
- 2030-12-01
- First posted
- 2016-02-19
- Last updated
- 2026-04-06
Locations
36 sites across 12 countries: Belgium, Canada, Germany, Hungary, Israel, Italy, Netherlands, Poland, Russia, South Korea, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT02686125. Inclusion in this directory is not an endorsement.